Concord Drugs Ltd

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	48.08	51.8	57.49	50.68	40.02
Other Income	0.09	0.14	0.09	0.2	0.37
Stock Adjustments	-0.46	3.2	0.4	0.28	0.68
Total Income	47.71	55.14	57.98	51.16	41.07
EXPENDITURE :
Raw Materials	39.14	46.5	46.51	39.22	31.9
Excise Duty	0	0	0	0	0
Power and Fuel Cost	0.78	0.7	0.97	0.77	0.34
Other Manufacturing Expenses	0.41	0.45	0.47	0.45	0.42
Employee Cost	2.29	1.73	2.57	1.61	0.44
Selling and Administration Expenses	0.77	0.97	1.84	0.6	0.56
Miscellaneous Expenses	0.58	-0.15	0.03	0.06	0.02
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	3.74	4.92	5.59	8.45	7.4
Interest and Financial Charges	1.59	1.88	2.36	2.57	2.72
Profit before Depreciation and Tax	2.15	3.04	3.23	5.88	4.68
Depreciation	1.71	2.4	2.58	2.91	3.63
Profit Before Tax	0.44	0.63	0.65	2.96	1.05
Tax	0.03	0.31	0.49	1.21	0.35
Profit After Tax	0.41	0.32	0.16	1.75	0.7
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	7.9	7.57	0	5.66	4.64
Appropriations	0	0	0.16	0	-0.33
P and L Bal. carried down	8.3	7.9	0	7.41	5.66
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	0.52	0.41	0.22	2.41	0.96
Book Value	29.45	24.58	26.22	20.8	18.38
Extraordinary Items	0	0	0	-0.03	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

48.08

51.8

57.49

50.68

40.02

Other Income

0.09

0.14

0.09

0.2

0.37

Stock Adjustments

-0.46

3.2

0.4

0.28

0.68

Total Income

47.71

55.14

57.98

51.16

41.07

EXPENDITURE :

Raw Materials

39.14

46.5

46.51

39.22

31.9

Excise Duty

Power and Fuel Cost

0.78

0.7

0.97

0.77

0.34

Other Manufacturing Expenses

0.41

0.45

0.47

0.45

0.42

Employee Cost

2.29

1.73

2.57

1.61

0.44

Selling and Administration Expenses

0.77

0.97

1.84

0.6

0.56

Miscellaneous Expenses

0.58

-0.15

0.03

0.06

0.02

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

3.74

4.92

5.59

8.45

7.4

Interest and Financial Charges

1.59

1.88

2.36

2.57

2.72

Profit before Depreciation and Tax

2.15

3.04

3.23

5.88

4.68

Depreciation

1.71

2.4

2.58

2.91

3.63

Profit Before Tax

0.44

0.63

0.65

2.96

1.05

Tax

0.03

0.31

0.49

1.21

0.35

Profit After Tax

0.41

0.32

0.16

1.75

0.7

Adjustment below Net Profit

P and L Balance brought forward

7.9

7.57

5.66

4.64

Appropriations

0.16

-0.33

P and L Bal. carried down

8.3

7.9

7.41

5.66

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

0.52

0.41

0.22

2.41

0.96

Book Value

29.45

24.58

26.22

20.8

18.38

Extraordinary Items

-0.03

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	7.86	7.86	7.24	7.24	7.24
Reserves and Surplus	15.29	11.46	11.75	7.82	6.07
Total Shareholders Funds	23.15	19.32	18.99	15.06	13.31
Secured Loans	9.8	12.7	12.86	14.58	8.37
Unsecured Loans	2.74	3.69	3.35	9.67	12.9
Total Debt	12.54	16.39	16.21	24.25	21.27
Total Liabilities	35.69	35.71	35.2	39.31	34.58
APPLICATION OF FUNDS :
Gross Block	30.84	30.79	28.52	27.47	28.16
Less: Accum. Depreciation	18.99	17.28	14.88	12.3	9.85
Net Block	11.85	13.51	13.64	15.17	18.31
Capital Work in Progress	0.29	0	0	0	0
Investments	0	0	0	0	0
Current Assets, Loans and Advances
Inventories	18.64	18.62	11.03	8.15	5.63
Sundry Debtors	48.43	71.17	15.65	25.48	27.4
Cash and Bank Balance	0.18	0.06	0.23	0.04	0.05
Loans and Advances	3.37	3.06	14.97	3.65	3.07
Less: Current Liab. and Prov.
Current Liabilities	46.95	70.33	19.93	11.27	19.15
Provisions	0.12	0.38	0.39	1.9	0.73
Net Current Assets	23.55	22.2	21.56	24.15	16.27
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	35.69	35.71	35.2	39.32	34.58
Contingent Liabilities	0	0	0	0.04	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

7.86

7.24

Reserves and Surplus

15.29

11.46

11.75

7.82

6.07

Total Shareholders Funds

23.15

19.32

18.99

15.06

13.31

Secured Loans

9.8

12.7

12.86

14.58

8.37

Unsecured Loans

2.74

3.69

3.35

9.67

12.9

Total Debt

12.54

16.39

16.21

24.25

21.27

Total Liabilities

35.69

35.71

35.2

39.31

34.58

APPLICATION OF FUNDS :

Gross Block

30.84

30.79

28.52

27.47

28.16

Less: Accum. Depreciation

18.99

17.28

14.88

12.3

9.85

Net Block

11.85

13.51

13.64

15.17

18.31

Capital Work in Progress

0.29

Investments

Current Assets, Loans and Advances

Inventories

18.64

18.62

11.03

8.15

5.63

Sundry Debtors

48.43

71.17

15.65

25.48

27.4

Cash and Bank Balance

0.18

0.06

0.23

0.04

0.05

Loans and Advances

3.37

3.06

14.97

3.65

3.07

Less: Current Liab. and Prov.

Current Liabilities

46.95

70.33

19.93

11.27

19.15

Provisions

0.12

0.38

0.39

1.9

0.73

Net Current Assets

23.55

22.2

21.56

24.15

16.27

Miscellaneous Expenses not w/o

Total Assets

35.69

35.71

35.2

39.32

34.58

Contingent Liabilities

0.04

Concord Drugs Ltd

Enjoy Lifetime Free Delivery Trade